Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial - Sircar, G; Goswami, R P; Sircar, D; Ghosh, A; Ghosh, P (Rheumatology (Oxford), 2018)